[Why benzodiazepines are still in wide use?]

Area of Science:

• Pharmacology
• Clinical Psychiatry
• Neurology

Context:

• Benzodiazepines, introduced in the 1960s, became mainstays in neurology and psychiatry for conditions like anxiety, insomnia, and seizures.
• Concerns regarding abuse, dependence, and adverse effects led to recommendations favoring reduced or short-term benzodiazepine use.
• The emergence of selective serotonin reuptake inhibitors (SSRIs) further influenced guidelines, often overshadowing benzodiazepines.

Purpose:

• To analyze the continued clinical use of benzodiazepines despite evolving treatment guidelines.
• To examine the reasons behind the frequent long-term prescription of benzodiazepines.
• To contrast the efficacy and adverse effect profiles of benzodiazepines and SSRIs in clinical practice.

Summary:

• Despite recommendations to limit their use, benzodiazepines are frequently prescribed long-term due to rapid onset, efficacy, patient preference, and withdrawal difficulties.
• Selective serotonin reuptake inhibitors (SSRIs), while favored by guidelines, can present challenges such as incomplete therapeutic response and more adverse effects.
• Clinical experience suggests that the shift from benzodiazepines to SSRIs may not always be appropriate, challenging current prescribing trends.

Impact:

• Highlights the discrepancy between clinical guidelines and actual prescribing practices for benzodiazepines.
• Underscores the importance of considering patient factors and comparative drug profiles in treatment decisions.
• Suggests a need for re-evaluation of the rationale behind the transition from benzodiazepines to SSRIs in certain patient populations.